GPR is significantly associated with AKI risk in TBI patients, which may be mediated by FB. We identified GPR as a new biomarker for assessing AKI risk in TBI patients, thereby offering fresh insights into prevention and treatment for this population.
Chen et al. (Fri,) studied this question.